NCT00006476 2013-06-26
Suramin in Treating Patients With Recurrent Bladder Cancer
National Cancer Institute (NCI)
Phase 1 Completed
Clinical Trials
3 trialsNCT00066768 2013-06-04
Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00001381 2008-03-04
A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder
National Institutes of Health Clinical Center (CC)
Phase 1 Completed